GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Cyclically Adjusted PB Ratio

Huadong Medicine Co (SZSE:000963) Cyclically Adjusted PB Ratio : 4.60 (As of May. 24, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Cyclically Adjusted PB Ratio?

As of today (2024-05-24), Huadong Medicine Co's current share price is ¥31.29. Huadong Medicine Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥6.80. Huadong Medicine Co's Cyclically Adjusted PB Ratio for today is 4.60.

The historical rank and industry rank for Huadong Medicine Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:000963' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.28   Med: 13.23   Max: 24.14
Current: 4.89

During the past years, Huadong Medicine Co's highest Cyclically Adjusted PB Ratio was 24.14. The lowest was 4.28. And the median was 13.23.

SZSE:000963's Cyclically Adjusted PB Ratio is ranked worse than
82.1% of 687 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs SZSE:000963: 4.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Huadong Medicine Co's adjusted book value per share data for the three months ended in Mar. 2024 was ¥12.515. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥6.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Huadong Medicine Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Huadong Medicine Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Cyclically Adjusted PB Ratio Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.02 7.08 8.72 8.41 6.37

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.99 7.22 6.71 6.37 4.56

Competitive Comparison of Huadong Medicine Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's Cyclically Adjusted PB Ratio falls into.



Huadong Medicine Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Huadong Medicine Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=31.29/6.8
=4.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huadong Medicine Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Huadong Medicine Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.515/115.2271*115.2271
=12.515

Current CPI (Mar. 2024) = 115.2271.

Huadong Medicine Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.701 98.200 1.996
201409 1.312 98.900 1.529
201412 1.451 99.000 1.689
201503 1.673 99.900 1.930
201506 1.626 99.500 1.883
201509 1.793 100.500 2.056
201512 1.901 100.600 2.177
201603 3.929 102.200 4.430
201606 3.803 101.400 4.322
201609 4.016 102.400 4.519
201612 4.160 102.600 4.672
201703 4.471 103.200 4.992
201706 4.380 103.100 4.895
201709 4.635 104.100 5.130
201712 4.797 104.500 5.289
201803 5.173 105.300 5.661
201806 5.136 104.900 5.642
201809 5.431 106.600 5.871
201812 5.680 106.500 6.145
201903 6.176 107.700 6.608
201906 6.311 107.700 6.752
201909 6.664 109.800 6.993
201912 7.035 111.200 7.290
202003 7.705 112.300 7.906
202006 7.766 110.400 8.106
202009 8.133 111.700 8.390
202012 8.355 111.500 8.634
202103 8.725 112.662 8.924
202106 8.897 111.769 9.172
202109 9.287 112.215 9.536
202112 9.475 113.108 9.653
202203 9.869 114.335 9.946
202206 9.915 114.558 9.973
202209 10.301 115.339 10.291
202212 10.592 115.116 10.602
202303 11.011 115.116 11.022
202306 11.136 114.558 11.201
202309 11.570 115.339 11.559
202312 11.997 114.781 12.044
202403 12.515 115.227 12.515

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Huadong Medicine Co  (SZSE:000963) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Huadong Medicine Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.
Executives
He Ru Fen Supervisors
Hu Bao Zhen Supervisors
Zhou Shun Hua Executives
Shao Ling Min Supervisors
Wan Ling Ling Executives
Fu Hang Director
Yue Jin Director
Chen Bo Secretary Dong
Qin Yun Supervisors
Li Bang Liang Directors, executives
Zhou Jin Bao Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines